• 111 (NASDAQ:YI) is projected to report earnings for its second quarter.
• Innate Pharma (NASDAQ:IPHA) is projected to report quarterly loss at $0.16 per share on revenue of $9.10 million.
• Upexi (NASDAQ:UPXI) is estimated to report quarterly loss at $0.11 per share on revenue of $5.80 million.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number :+852 3852 8500
English